Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Antimicrobial use trends, Israel, 2012 to 2017.

Dickstein Y, Temkin E, Ben-David D, Carmeli Y, Schwaber MJ.

Euro Surveill. 2019 Aug;24(34). doi: 10.2807/1560-7917.ES.2019.24.34.1900022.

2.

The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey.

Ben-David D, Vaturi A, Solter E, Temkin E, Carmeli Y, Schwaber MJ; Israel CLABSI Prevention Working Group.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1094-1099. doi: 10.1017/ice.2019.190. Epub 2019 Jul 24. Erratum in: Infect Control Hosp Epidemiol. 2019 Nov;40(11):1332.

PMID:
31339089
3.

Trends in antimicrobial resistance in Israel, 2014-2017.

Dickstein Y, Temkin E, Ish Shalom M, Schwartz D, Carmeli Y, Schwaber MJ.

Antimicrob Resist Infect Control. 2019 Jun 4;8:96. doi: 10.1186/s13756-019-0535-1. eCollection 2019.

4.

ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.

Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J.

Clin Microbiol Infect. 2019 Jul;25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.

5.

Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel's Long-term Care Facilities.

Ben-David D, Masarwa S, Fallach N, Temkin E, Solter E, Carmeli Y, Schwaber MJ; Israel LTCF CRE Working Group.

Clin Infect Dis. 2019 Mar 5;68(6):964-971. doi: 10.1093/cid/ciy572.

PMID:
29986007
6.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodriguez-Gomez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual A, Rodríguez-Baño J, Venditti M; REIPI/ESGBIS/INCREMENT investigators.

Int J Antimicrob Agents. 2018 Nov;52(5):577-585. doi: 10.1016/j.ijantimicag.2018.06.018. Epub 2018 Jun 30.

PMID:
29969692
7.

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.

Scheuerman O, Schechner V, Carmeli Y, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Molina J, Hernández-Torres A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Navarro-San Francisco C, Bonomo RA, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT investigators.

Infect Control Hosp Epidemiol. 2018 Jun;39(6):660-667. doi: 10.1017/ice.2018.63. Epub 2018 Apr 5.

PMID:
29618394
8.

Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.

Solter E, Adler A, Rubinovitch B, Temkin E, Schwartz D, Ben-David D, Masarwa S, Carmeli Y, Schwaber MJ.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):85-89. doi: 10.1017/ice.2017.211. Epub 2017 Dec 15.

PMID:
29241475
9.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.

Palacios-Baena ZR, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina Gil-Bermejo J, Hernández A, Venditti M, Prim N, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Paño-Pardo JR, Torre-Cisneros J, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual Á, Rodríguez-Baño J; Spanish Network for Research in Infectious Diseases (REIPI)/European Study Group of Bloodstream Infections and Sepsis (ESGBIS)/INCREMENT Group.

Clin Infect Dis. 2017 Oct 30;65(10):1615-1623. doi: 10.1093/cid/cix606.

10.
11.

Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.

Harris PNA, Pezzani MD, Gutiérrez-Gutiérrez B, Viale P, Hsueh PR, Ruiz-Garbajosa P, Venditti M, Tumbarello M, Navarro-Francisco C, Calbo E, Akova M, Giamarellou H, Oliver A, Almirante B, Gasch O, Martínez-Martínez L, Schwaber MJ, Daikos G, Pitout J, Peña C, Hernández-Torres A, Doi Y, Pérez F, Tuon FF, Tacconelli E, Carmeli Y, Bonomo RA, Pascual Á, Paterson DL, Rodríguez-Baño J; ESGBIS/REIPI/INCREMENT Group.

Int J Antimicrob Agents. 2017 Nov;50(5):664-672. doi: 10.1016/j.ijantimicag.2017.08.005. Epub 2017 Aug 3.

PMID:
28782704
12.

Evolution and dissemination of the Klebsiella pneumoniae clonal group 258 throughout Israeli post-acute care hospitals, 2008-13.

Adler A, Lifshitz Z, Gordon M, Ben-David D, Khabra E, Masarwa S, Zion O, Schwaber MJ, Carmeli Y.

J Antimicrob Chemother. 2017 Aug 1;72(8):2219-2224. doi: 10.1093/jac/dkx135.

PMID:
28486697
13.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cantón R, Doi Y, Tuon FF, Karaiskos I, Pérez-Nadales E, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators.

Lancet Infect Dis. 2017 Jul;17(7):726-734. doi: 10.1016/S1473-3099(17)30228-1. Epub 2017 Apr 22.

PMID:
28442293
14.

Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.

Friedman ND, Carmeli Y, Walton AL, Schwaber MJ.

Infect Control Hosp Epidemiol. 2017 May;38(5):580-594. doi: 10.1017/ice.2017.42. Epub 2017 Mar 15. Review. Erratum in: Infect Control Hosp Epidemiol. 2017 Sep;38(9):1136.

PMID:
28294079
15.

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.

Palacios-Baena ZR, Gutiérrez-Gutiérrez B, De Cueto M, Viale P, Venditti M, Hernández-Torres A, Oliver A, Martínez-Martínez L, Calbo E, Pintado V, Gasch O, Almirante B, Antonio Lepe J, Pitout J, Akova M, Peña-Miralles C, Schwaber MJ, Tumbarello M, Tacconelli E, Origüen J, Prim N, Bou G, Giamarellou H, Bermejo J, Hamprecht A, Pérez F, Almela M, Lowman W, Hsueh PR, Navarro-San Francisco C, Torre-Cisneros J, Carmeli Y, Bonomo RA, Paterson DL, Pascual Á, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Group.

J Antimicrob Chemother. 2017 Mar 1;72(3):906-913. doi: 10.1093/jac/dkw513.

16.

Gentamicin- and Ciprofloxacin-Resistant Enterobacteriaceae in Cattle Farms in Israel: Risk Factors for Carriage and the Effect of Microbiological Methodology on the Measured Prevalence.

Adler A, Sturlesi N, Fallach N, Zilberman-Barzilai D, Hussein O, Blum SE, Klement E, Schwaber MJ, Carmeli Y.

Microb Drug Resist. 2017 Jul;23(5):660-665. doi: 10.1089/mdr.2016.0052. Epub 2016 Nov 9.

PMID:
27828758
17.

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Pintado V, Doi Y, Tuon FF, Karaiskos I, Machuca I, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; Investigators from the REIPI/ESGBIS/INCREMENT Group.

Mayo Clin Proc. 2016 Oct;91(10):1362-1371. doi: 10.1016/j.mayocp.2016.06.024. Erratum in: Mayo Clin Proc. 2016 Dec;91(12 ):1843.

PMID:
27712635
18.

Correction for Adler et al., Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013.

Adler A, Sturlesi N, Fallach N, Zilberman-Barzilai D, Hussein O, Blum SE, Klement E, Schwaber MJ, Carmeli Y.

J Clin Microbiol. 2016 Jun;54(6):1671. doi: 10.1128/JCM.00665-16. No abstract available.

19.

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.

Gutiérrez-Gutiérrez B, Pérez-Galera S, Salamanca E, de Cueto M, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina J, Hernández A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Natera C, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4159-69. doi: 10.1128/AAC.00365-16. Print 2016 Jul.

20.

Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among patients prior to bowel surgery.

Pfeffer I, Zemel M, Kariv Y, Mishali H, Adler A, Braun T, Klein A, Matalon MK, Klausner J, Carmeli Y, Schwaber MJ.

Diagn Microbiol Infect Dis. 2016 Jul;85(3):377-380. doi: 10.1016/j.diagmicrobio.2016.04.002. Epub 2016 Apr 8.

PMID:
27133560
21.

Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.

Gutiérrez-Gutiérrez B, Bonomo RA, Carmeli Y, Paterson DL, Almirante B, Martínez-Martínez L, Oliver A, Calbo E, Peña C, Akova M, Pitout J, Origüen J, Pintado V, García-Vázquez E, Gasch O, Hamprecht A, Prim N, Tumbarello M, Bou G, Viale P, Tacconelli E, Almela M, Pérez F, Giamarellou H, Cisneros JM, Schwaber MJ, Venditti M, Lowman W, Bermejo J, Hsueh PR, Mora-Rillo M, Gracia-Ahulfinger I, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Group.

J Antimicrob Chemother. 2016 Jun;71(6):1672-80. doi: 10.1093/jac/dkv502. Epub 2016 Feb 22.

22.

Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel.

Lerner A, Solter E, Rachi E, Adler A, Rechnitzer H, Miron D, Krupnick L, Sela S, Aga E, Ziv Y, Peretz A, Labay K, Rahav G, Geffen Y, Hussein K, Eluk O, Carmeli Y, Schwaber MJ.

Eur J Clin Microbiol Infect Dis. 2016 Jan;35(1):149-54. doi: 10.1007/s10096-015-2520-9. Epub 2015 Nov 18.

PMID:
26581423
23.

Pro-Arrhythmic Effects of Noncardiac Medications: Lessons From Macrolide Antibiotics.

Viskin S, Havakuk O, Schwaber MJ.

J Am Coll Cardiol. 2015 Nov 17;66(20):2185-2188. doi: 10.1016/j.jacc.2015.09.027. No abstract available.

24.

Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013.

Adler A, Sturlesi N, Fallach N, Zilberman-Barzilai D, Hussein O, Blum SE, Klement E, Schwaber MJ, Carmeli Y.

J Clin Microbiol. 2015 Nov;53(11):3515-21. doi: 10.1128/JCM.01915-15. Epub 2015 Aug 26. Erratum in: J Clin Microbiol. 2016 Jun;54(6):1671.

25.

A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole.

Adler A, Miller-Roll T, Bradenstein R, Block C, Mendelson B, Parizade M, Paitan Y, Schwartz D, Peled N, Carmeli Y, Schwaber MJ.

Diagn Microbiol Infect Dis. 2015 Sep;83(1):21-4. doi: 10.1016/j.diagmicrobio.2015.05.015. Epub 2015 Jun 3.

PMID:
26116225
26.

Methicillin-Resistant Staphylococcus aureus spa Type t002 Outbreak in Horses and Staff at a Veterinary Teaching Hospital after Its Presumed Introduction by a Veterinarian.

Steinman A, Masarwa S, Tirosh-Levy S, Gleser D, Kelmer G, Adler A, Carmeli Y, Schwaber MJ.

J Clin Microbiol. 2015 Sep;53(9):2827-31. doi: 10.1128/JCM.00090-15. Epub 2015 Jun 17.

27.

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.

Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y.

Clin Microbiol Infect. 2015 Jan;21(1):30-4. doi: 10.1016/j.cmi.2014.08.001. Epub 2014 Oct 12.

28.

Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13.

Adler A, Hussein O, Ben-David D, Masarwa S, Navon-Venezia S, Schwaber MJ, Carmeli Y; Post-Acute-Care Hospital Carbapenem-Resistant Enterobacteriaceae Working Group.

J Antimicrob Chemother. 2015 Jan;70(1):89-92. doi: 10.1093/jac/dku333. Epub 2014 Sep 8.

PMID:
25204343
29.

A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.

Ben-David D, Masarwa S, Adler A, Mishali H, Carmeli Y, Schwaber MJ.

Infect Control Hosp Epidemiol. 2014 Jul;35(7):802-9. doi: 10.1086/676876.

PMID:
24915207
30.

Persistence and complex evolution of fluoroquinolone-resistant Streptococcus pneumoniae clone.

Ben-David D, Schwaber MJ, Adler A, Masarwa S, Edgar R, Navon-Venezia S, Schwartz D, Porat N, Kotlovsky T, Polivkin N, Weinberg I, Lazary A, Ohana N, Dagan R.

Emerg Infect Dis. 2014 May;20(5):799-805. doi: 10.3201/eid2005.130142.

31.

Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey.

Adler A, Schwartzberg Y, Samra Z, Schwartz O, Carmeli Y, Schwaber MJ; Israeli Clostridium difficile Diagnostics Study Group.

Clin Microbiol Infect. 2014 Nov;20(11):O904-10. doi: 10.1111/1469-0691.12634. Epub 2014 May 15.

32.

Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.

Bilavsky E, Temkin E, Lerman Y, Rabinovich A, Salomon J, Lawrence C, Rossini A, Salvia A, Samso JV, Fierro J, Paul M, Hart J, Gniadkowski M, Hochman M, Kazma M, Klein A, Adler A, Schwaber MJ, Carmeli Y; MOSAR WP5 study team.

Clin Microbiol Infect. 2014 Nov;20(11):O804-10. doi: 10.1111/1469-0691.12633. Epub 2014 May 15.

33.

Emergence of VIM-producing Aeromonas caviae in Israeli hospitals.

Adler A, Assous MV, Paikin S, Shulman A, Miller-Roll T, Hillel S, Aronov R, Carmeli Y, Schwaber MJ.

J Antimicrob Chemother. 2014 May;69(5):1211-4. doi: 10.1093/jac/dkt505. Epub 2014 Jan 2.

PMID:
24390932
34.

An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.

Schwaber MJ, Carmeli Y.

Clin Infect Dis. 2014 Mar;58(5):697-703. doi: 10.1093/cid/cit795. Epub 2013 Dec 4. Review. Erratum in: Clin Infect Dis. 2014 Jul 15;59(2):323.

PMID:
24304707
35.

Postexposure prophylaxis of tick-borne relapsing fever: lessons learned from recent outbreaks in Israel.

Moran-Gilad J, Levine H, Schwartz E, Bartal C, Huerta-Hartal M, Schwaber MJ, Ostfeld I.

Vector Borne Zoonotic Dis. 2013 Nov;13(11):791-7. doi: 10.1089/vbz.2013.1347. Epub 2013 Oct 9.

PMID:
24107216
36.

Targeted decolonization to prevent ICU infections.

Schwaber MJ, Rubinovitch B, Carmeli Y.

N Engl J Med. 2013 Oct 10;369(15):1470. doi: 10.1056/NEJMc1309704. No abstract available.

PMID:
24106947
37.

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP.

Lancet Infect Dis. 2013 Sep;13(9):785-96. doi: 10.1016/S1473-3099(13)70190-7. Review.

38.

Epidemiological and microbiological characteristics of an outbreak caused by OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Jerusalem, Israel.

Adler A, Solter E, Masarwa S, Miller-Roll T, Abu-Libdeh B, Khammash H, Najem K, Dekadek S, Stein-Zamir C, Nubani N, Kunbar A, Assous MV, Carmeli Y, Schwaber MJ.

J Clin Microbiol. 2013 Sep;51(9):2926-30. doi: 10.1128/JCM.01049-13. Epub 2013 Jun 26.

39.

Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ.

Clin Microbiol Rev. 2013 Apr;26(2):289-307. doi: 10.1128/CMR.00001-13. Review.

40.

Clonal transmission of a rare methicillin-resistant Staphylococcus aureus genotype between horses and staff at a veterinary teaching hospital.

Schwaber MJ, Navon-Venezia S, Masarwa S, Tirosh-Levy S, Adler A, Chmelnitsky I, Carmeli Y, Klement E, Steinman A.

Vet Microbiol. 2013 Mar 23;162(2-4):907-911. doi: 10.1016/j.vetmic.2012.11.020. Epub 2012 Nov 26.

PMID:
23265243
41.

Prevalence of Streptococcus pneumoniae in respiratory samples from patients with tracheostomy in a long-term-care facility.

Adler A, Ben-David D, Schwaber MJ, Masarwa S, Schwartz D, Porat N, Kotlovsky T, Shklyar M, Polivkin N, Weinberg I, Lazary A, Ohana N, Dagan R.

J Clin Microbiol. 2012 Oct;50(10):3368-70. doi: 10.1128/JCM.00763-12. Epub 2012 Jul 25.

42.

A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.

Adler A, Paikin S, Sterlin Y, Glick J, Edgar R, Aronov R, Schwaber MJ, Carmeli Y.

J Clin Microbiol. 2012 Oct;50(10):3180-5. doi: 10.1128/JCM.00987-12. Epub 2012 Jul 18.

43.

Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?

Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S, Schwaber MJ, Carmeli Y.

Clin Microbiol Infect. 2013 May;19(5):451-6. doi: 10.1111/j.1469-0691.2012.03888.x. Epub 2012 May 7.

44.

Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres--a prospective study.

Bilavsky E, Lerman Y, Rabinovich A, Salomon J, Lawrence C, Rossini A, Salvia A, Samso JV, Fierro J, Hochman M, Kazma M, Klein A, Schwaber MJ, Carmeli Y; MOSAR WP5 study team.

Clin Microbiol Infect. 2012 Jun;18(6):E164-9. doi: 10.1111/j.1469-0691.2012.03851.x. Epub 2012 Apr 18.

45.

Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism.

Adler A, Shklyar M, Schwaber MJ, Navon-Venezia S, Dhaher Y, Edgar R, Solter E, Benenson S, Masarwa S, Carmeli Y.

J Antimicrob Chemother. 2011 Dec;66(12):2763-6.

PMID:
22191089
46.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Israel: dissemination of global clones and unique features.

Adler A, Chmelnitsky I, Shitrit P, Sprecher H, Navon-Venezia S, Embon A, Khabra E, Paitan Y, Keren L, Halperin E, Carmeli Y, Schwaber MJ.

J Clin Microbiol. 2012 Jan;50(1):134-7. doi: 10.1128/JCM.05446-11. Epub 2011 Oct 26.

47.

High prevalence of methicillin-resistant Staphylococcus aureus among residents and staff of long-term care facilities, involving joint and parallel evolution.

Schwaber MJ, Masarwa S, Navon-Venezia S, Kandlik Y, Chmelnitsky I, Smollan G, Glick R, Neria G, Carmeli Y.

Clin Infect Dis. 2011 Nov;53(9):910-3. doi: 10.1093/cid/cir607. Erratum in: Clin Infect Dis. 2012 Oct;55(8):1170.

PMID:
21984272
48.

Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.

Ben-David D, Masarwa S, Navon-Venezia S, Mishali H, Fridental I, Rubinovitch B, Smollan G, Carmeli Y, Schwaber MJ; Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group.

Infect Control Hosp Epidemiol. 2011 Sep;32(9):845-53. doi: 10.1086/661279. Erratum in: Infect Control Hosp Epidemiol. 2014 Sep;35(9):1208.

PMID:
21828964
49.

Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.

Schechner V, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Finkelstein R, Lachish T, Wiener-Well Y, Alon D, Chowers M, Bardenstein R, Zimhony O, Paz A, Potasman I, Giladi M, Schwaber MJ, Klarfeld-Lidji S, Hochman M, Marchaim D, Carmeli Y.

Diagn Microbiol Infect Dis. 2011 Sep;71(1):38-45. doi: 10.1016/j.diagmicrobio.2011.05.010. Epub 2011 Jul 16.

PMID:
21763093
50.

The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study.

Carmeli Y, Lidji SK, Shabtai E, Navon-Venezia S, Schwaber MJ.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):367-72. doi: 10.1016/j.diagmicrobio.2011.03.009.

PMID:
21683268

Supplemental Content

Loading ...
Support Center